Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 1, 2008, Pages 142-149

  Mitani, Yoshihide ^a   Maruyama, Junko ^a   Jiang, Bao Hua ^a   Sawada, Hirofumi ^a   Shimpo, Hideto ^a   Imanaka Yoshida, Kyoko ^a   Kaneda, Yasufumi ^b   Komada, Yoshihiro ^a   Maruyama, Kazuo ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA GALACTOSIDASE; HEMAGGLUTINATING VIRUS OF JAPAN ENVELOPE VECTOR; VASCULAR CELL ADHESION MOLECULE 1; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BRONCHUS MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; HEART RIGHT VENTRICLE HYPERTROPHY; HEMATOCRIT; HEMODYNAMICS; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; MORPHOMETRICS; NONHUMAN; PARAINFLUENZA VIRUS; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE THERAPY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BETA-GALACTOSIDASE; DISEASE MODELS, ANIMAL; ENDOTHELIUM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYPERTENSION, PULMONARY; LUNG; RANDOM ALLOCATION; RATS; RATS, WISTAR; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1; VIRAL ENVELOPE PROTEINS;

EID: 46049093967     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.10.061     Document Type: Article

References (28)

1. Newman K.D., Dunn P.F., Owens J.W., Schulick A.H., Virmani R., Sukhova G., et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96 (1995) 2955-2965
2. Gauldie J., Graham F., Xing Z., Braciak T., Foley R., and Sime P.J. Adenovirus-vector-mediated cytokine gene transfer to lung tissue. Ann N Y Acad Sci 796 (1996) 235-244
3. Crystal R.G., Mastrangeli A., Sanders A., Cooke J., King T., Gilbert F., et al. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis. Hum Gene Ther 6 (1995) 667-703
4. Piedimonte G., Pickles R.J., Lehmann J.R., McCarty D., Costa D.L., and Boucher R.C. Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation. Am J Respir Cell Mol Biol 16 (1997) 250-258
5. Cornetta K., Morgan R.A., and Anderson W.F. Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 2 (1991) 5-14
6. Kearns W.G., Afione S.A., Fulmer S.B., Pang M.C., Erikson D., Egan M., et al. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther 3 (1996) 748-755
7. Kaneda Y., Nakajima T., Nishikawa T., Yamamoto S., Ikegami H., Suzuki N., et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 6 (2002) 219-226
8. Nagaya N., Yokoyama C., Kyotani S., Shimonishi M., Morishita R., Uematsu M., et al. Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats. Circulation 102 (2000) 2005-2010
9. Mitani Y., Maruyama J., Yokochi A., Maruyama K., Yoshimoto T., Naruse M., et al. Modulated vasodilator responses to natriuretic peptides in rats exposed to chronic hypoxia. Eur Respir J 15 (2000) 400-406
10. Jin H.K., Yang R.H., Thornton R.M., Chen Y.F., Jackson R., and Oparil S. Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats. J Appl Physiol 65 (1988) 1729-1735
11. Jin H., Yang R.H., Chen Y.F., Jackson R.M., and Oparil S. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. J Clin Invest 85 (1990) 115-120
12. Winter R.J., Zhao L., Krausz T., and Hughes J.M. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia. Am Rev Respir Dis 144 (1991) 1342-1346
13. Morishita R., Gibbons G.H., Pratt R.E., Tomita N., Kaneda Y., Ogihara T., et al. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. J Clin Invest 94 (1994) 824-829
14. Tsujie M., Isaka Y., Ando Y., Akagi Y., Kaneda Y., Ueda N., et al. Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method. Kidney Int 57 (2000) 1973-1980
15. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
16. Yamanaka M., Greenberg B., Johnson L., Seilhamer J., Brewer M., Friedemann T., et al. Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor. Nature 309 (1984) 719-722
17. Sawada H., Mitani M., Maruyama J., Jiang B.H., Ikeyama Y., Dida F.A., et al. A nuclear factor-κB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest 132 (2007) 1265-1274
18. Mitani Y., Maruyama K., and Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96 (1997) 689-697
19. Maruyama J., Maruyama K., Mitani Y., Kitabatake M., Yamauchi T., and Miyasaka K. Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 272 (1997) H517-H524
20. Maruyama K., Ye C.L., Woo M., Venkatacharya H., Lines L.D., Silver M.M., et al. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol Heart Circ Physiol 261 (1991) H1716-H1726
21. Shimamura M., Morishita R., Endoh M., Oshima K., Aoki M., Waguri S., et al. HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun 300 (2003) 464-471
22. Nakamura H., Kimura T., Ikegami H., Ogita K., Koyama S., Shimoya K., et al. Highly efficient and minimally invasive in-vivo gene transfer to the mouse uterus using haemagglutinating virus of Japan envelope vector. Mol Hum Reprod 9 (2003) 603-609
23. Saeki Y., Wataya-Kaneda M., Tanaka K., and Kaneda Y. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes. Gene Ther 5 (1998) 1031-1037
24. Louzier V., Eddahibi S., Raffestin B., Deprez I., Adam M., Levame M., et al. Adenovirus-mediated atrial natriuretic protein expression in the lung protects rats from hypoxia-induced pulmonary hypertension. Hum Gene Ther 12 (2001) 503-513
25. Champion H.C., Bivalacqua T.J., Toyoda K., Heistad D.D., Hyman A.L., and Kadowitz P.J. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation 101 (2000) 923-930
26. Michelakis E.D., Tymchak W., Noga M., Webster L., Wu X.C., Lien D., et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108 (2003) 2066-2069
27. Angus R.M., Millar E.A., Chalmers G.W., and Thomson N.C. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP). Thorax 51 (1996) 71-74
28. Mitani Y., Zaidi S.H., Dufourcq P., Thompson K., and Rabinovitch M. Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning. FASEB J 14 (2000) 805-814